CLNN shows severe financial deterioration with stockholders' equity nearly doubling in deficit to -$17.6M, cash declining 57% to $5.2M, and warrants expiring unexercised, indicating significant distress.
The company is burning through cash rapidly while facing mounting losses and deteriorating equity position, creating serious liquidity concerns. The expiration of all warrants unexercised suggests investors have no confidence in the stock's recovery potential, eliminating a key source of potential capital.
CLNN experienced comprehensive financial deterioration across all metrics, with revenue declining 41% to $200K while interest expense surged 38% to $4.6M, reflecting mounting debt burden. Despite net losses improving from -$39.4M to -$26.2M, this appears driven by one-time factors rather than operational improvement given the revenue decline and cash burn. The company's balance sheet shows severe stress with stockholders' equity deficit nearly doubling, cash reserves falling 57% to $5.2M, and total assets shrinking 34%, signaling potential liquidity crisis and raising going concern questions.
Capital expenditure jumped 160% — major investment cycle underway; assess returns on deployment.
Equity declined sharply — large losses, buybacks, or write-downs reducing book value significantly.
Cash declined 57.3% — significant cash burn or deployment; verify adequacy of remaining liquidity runway.
Inventory drawn down 45.6% — strong sell-through or deliberate destocking; watch for supply constraints.
Current assets declined 44.4% — monitor working capital adequacy and short-term liquidity.
Revenue declined 41.5% — significant demand weakness or market share loss warrants investigation.
Interest expense surged 38.3% — significant debt increase or rising rates materially impacting earnings.
Total assets contracted 33.7% — asset sales, write-downs, or balance sheet optimization underway.
Net income grew 33.6% — bottom-line growth signals improving overall business health.
Operating leverage kicking in — revenue growth outpacing cost growth, a hallmark of scaling businesses.
See what changed in your portfolio's filings
500+ US-listed companies analyzed. Language delta, financial analysis, instant signal scoring.
Try Tracenotes free →